What is the main business of Ardea Polska?

The main business activity of Ardea Polska focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 12, 2007.

Where is the headquarters located?

The headquarters is located at: ul. Kinga C. Gillette 11, 94-406 Łódź.

Who is on the management board?

The management board includes: Bożena Helena Szymańska (President of the Management Board) and Katarzyna Ewa Nockowska Stańczak (Vice President of the Management Board).

What is the share capital?

The share capital of the company is PLN 208,000 (approx. $56,186).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of $4,056,073, representing an increase of 13.1% compared to 2024.

No, in 2025 the company was not profitable, reporting a net loss of $32,319. For comparison, in 2024 the loss was $47,086, meaning the company reduced its loss by 31.5%.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $3,219,885 in 2025, representing 79% of all operating expenses.

Ardea Polskasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2007-03-12

Share capital

208 000,00 PLN

Registered address

ul. Kinga C. Gillette 11, 94-406 Łódź, Poland

Electronic delivery address

AE:PL-79208-35769-GGRJJ-17

Financials

Revenue history (in k)

Financial insight

Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 4.06mMedianUSD 1.75mAverageUSD 5.00m

Net profit

This companyUSD -32.32kMedianUSD 17.49kAverageUSD 85.24k

Operating costs

This companyUSD 4.06mMedianUSD 1.72mAverageUSD 4.85m

Assets

This companyUSD 741.11kMedianUSD 495.38kAverageUSD 1.71m

Industry

Bank accounts

Registered as a VAT taxpayer on 2007-05-01. Active

Erste Bank Polska
26 1090 1304 0000 0001 5217 0217
ING Bank Śląski
36 1050 0086 1000 0090 3242 0821
Erste Bank Polska
37 1090 1304 0000 0001 1677 8987

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

4 public aid cases recorded, with a total value of $18,473.

Grant date	Purpose	Gross amount	Granting body
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,670$3,670	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,884$3,884	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	$3,776$3,776	Prezes Zakładu Ubezpieczeń Społecznych

Tenders

No recorded participation in tenders.

National Health Fund (NFZ) contracts

Ardea Polska has been an NFZ healthcare provider since 2019. In 2026 it is performing 3 contracts with a total value of USD 459.21. All its contracts were worth USD 672.53 in total.

NFZ contract value by year (USD)

Type of care	NFZ branch	Contracts	Value in 2026
Programy pilotażowe	wielkopolskie	1	USD 459.21
Inne usługi realizowane w aptekach	wielkopolskie	2	USD 0.00

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Authorized Representatives

Aleksandra Olszacka – Vice President of the Management Board

Bożena Helena Szymańska – President of the Management Board

Katarzyna Nockowska Stańczak – Vice President of the Management Board

Manner of representation

If a multi-member management board is appointed, two members of the management board acting jointly, or one member of the management board acting together with a commercial proxy, are authorized to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
DOZ S.A.	25	$13,506.21	24.0385%
Przedsiębiorstwo Farmaceutyczne Apexim S.A.	79	$42,679.63	75.9615%

Beneficial owners

Person	Rights

Competitors

Name	Revenue	Website
Fragalsp. z o.o.	$5,374,285.81	aptekafragal.pl
Modrzewscysp. j.	$5,602,358.99	aptekacentrum.lublin.pl
Ms-Pharmsp. z o.o. + limited partnership	$4,619,501.46	mspharm.pl
Farmjug Agsp. z o.o.	$4,213,734.86	farmjug.pl
MagmaxS.A.	$4,200,912.15	magmaxsa.pl
Adpharmasp. z o.o.	$4,026,799.19	adamed.com
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.	$3,414,382.70	aptekazielona.com.pl
Novopharm - Millersp. j.	$2,839,228.36	apteka.zyj-zdrowo.com
Pikadasp. z o.o.	$1,903,088.18	apteka-propharma.pl
Awicennasp. j.	–	a-medyczny.pl

Change history

Date	Event
2024-12-30	Address change (Jaworowa 66, 61-454, Poznań → Ul. Kinga C. Gillette 11, 94-406, Łódź)
2018-01-26	Share capital change (200,000.00 PLN → 208,000.00 PLN)
2015-06-30	PKD change (Removed: 10.86.Z, 10.89.Z, 21.10.Z, 49.41.Z, 63.11.Z, 63.12.Z, 64.20.Z, 68.10.Z, 68.20.Z, 70.10.Z, 70.22.Z, 73.20.Z, 77.11.Z, 77.12.Z, 77.33.Z, 77.39.Z, 78.10.Z, 78.30.Z, 82.30.Z, 82.99.Z, 85.59.B)
2010-09-17	PKD change (Removed: 22.1, 52.31.Z, 52.32.Z, 52.33, 55, 63.3, 70.1, 70.2, 70.3, 71.3, 74.14, 74.4, 74.50, 74.8, 93.05; Added: 10.86.Z, 10.89.Z, 21.10.Z, 21.20.Z, 47.19.Z, 47.29.Z, 47.73.Z, 47.74.Z, 47.75.Z, 47.91.Z, 49.41.Z, 52.10.B, 63.11.Z, 63.12.Z, 64.20.Z, 64.99.Z, 68.10.Z, 68.20.Z, 70.10.Z, 70.22.Z, 73.20.Z, 77.11.Z, 77.12.Z, 77.33.Z, 77.39.Z, 78.10.Z, 78.30.Z, 82.30.Z, 82.99.Z, 85.59.B, 86.90.E)
2008-01-25	Address change (Jachowicza 43, 60-195, Poznań → Jaworowa 66, 61-454, Poznań)

FAQ

Last updated: 2026-06-01